Forodesine Hydrochloride from Japan
Forodesine HCl is a purine nucleoside phosphorylase inhibitor with transition state analog structure for T-cell malignancies. The aromatic heterocyclic hydrochloride salt qualifies as a drug under HTS 2934.99.30.00.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.628.5%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.900%Articles of aluminum, of steel or of copper or derivative aluminum or steel articles; passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; parts of passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; medium- and heavy-duty vehicles; parts of medium- and heavy-duty vehicles; wood products; patented pharmaceutical articles; and semiconductor articles, as provided in subdivision (f) of U.S. note 52 to this subchapter
Import Tips
• Specify hydrochloride salt form stability and counterion exchange prevention
• Provide orphan drug and fast track designation documentation
• Document high potency API handling requirements (glove box filling)